Login
Companies $BDX
$216.47 +$0.00 (0.0%) After hours
BECTON DICKINSON & CO logo

BECTON DICKINSON & CO

bd.com

What Do They Do?

Makes medical supplies and devices for hospitals, clinics and pharmaceutical companies, including drug-delivery and medication-management systems.

How Do They Make Money?

BD mainly sells products, with payment generally tied to shipment or delivery; complex equipment installations are paid for after customer acceptance. It also earns revenue from service arrangements over their contract terms.

revenue
SegmentShareRevenue
Medical
Sold outright

52%
FY2022: 47%
Life Sciences
Sold outright

24%
FY2022: 29%
Interventional
Sold outright

24%
FY2022: 24%

Who Are Their Customers?

Hospitals, clinics, laboratories, pharmaceutical companies and healthcare professionals buy BD products. BD sells through independent distributors and directly to end users through BD and independent sales representatives.

Do Revenues Turn Into Profits?

Yes. It kept 8 cents of every revenue dollar as net income in FY2025 and turned 12 cents into free cash flow.

Operating income, FY2025
12% of revenue
▲ +8% vs FY2024 ($2.4B, 12%)
Net income, FY2025
8% of revenue
▼ −2% vs FY2024 ($1.7B, 8%)
Free cash flow, FY2025
12% of revenue
▼ −13% vs FY2024 ($3.1B, 15%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Jun 30, 2026
Revenue
▲ +5%
vs $4.7B in Q3 FY2025
Net income
▼ −34%
vs $574M in Q3 FY2025
  • Aug 6, 2026 BD raised its full-year adjusted earnings outlook It expects revenue growth toward the high end of its range and raised the midpoint of adjusted diluted EPS guidance.
  • Feb 9, 2026 BD completed the Biosciences and Diagnostics combination with Waters BD received $4 billion in cash as part of the transaction.

Growing. Revenue grew 14% in 4 years, from $19.1B in FY2021 to $21.8B in FY2025, about 3% a year.

Patient monitoring added BD added advanced patient monitoring systems to Medical, including systems that measure heart function and fluid status in surgical and intensive-care settings.

Surgical Instrumentation sold BD sold its Surgical Instrumentation platform; the older report listed surgical and laparoscopic instruments in Surgery, while the latest describes Surgery products without that platform.

Revenue over time
Medical Life Sciences Interventional
$25B$12.5B$0

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support